These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 1342879

  • 41. [Lupus erythematosus of the skin. An analysis of 97 patients].
    Tebbe B, Orfanos CE.
    Z Hautkr; 1987 Nov 15; 62(22):1563-72, 1577-8, 1583-4. PubMed ID: 3501642
    [Abstract] [Full Text] [Related]

  • 42. [Subacute cutaneous lupus erythematosus. Review of the literature and immunological studies of 11 patients].
    Fabbri P, Bernacchi E, Neri R.
    G Ital Dermatol Venereol; 1990 Aug 15; 125(7-8):329-36. PubMed ID: 2289815
    [Abstract] [Full Text] [Related]

  • 43. Papular lesions and cutaneous lupus erythematosus: a comparative clinical and histological study using monoclonal antibodies.
    McHugh NJ, Maddison PJ, MacCleod TI, Dean SG, James IE, Goulding NJ, Tan RS.
    J Rheumatol; 1988 Jul 15; 15(7):1097-103. PubMed ID: 2459383
    [Abstract] [Full Text] [Related]

  • 44. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
    Avilés Izquierdo JA, Cano Martínez N, Lázaro Ochaita P.
    Actas Dermosifiliogr; 2014 Jul 15; 105(1):69-73. PubMed ID: 24268922
    [Abstract] [Full Text] [Related]

  • 45. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M, Regnier-Rosencher E, Carlotti A, Goulvestre C, Le Guern V, Mouthon L, Avril MF, Dupin N.
    Dermatology; 2013 Jul 15; 226(2):119-23. PubMed ID: 23548825
    [Abstract] [Full Text] [Related]

  • 46. [ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. A new subset of lupus with characteristic skin manifestations].
    Bardach H.
    Hautarzt; 1982 Oct 15; 33(10):537-41. PubMed ID: 6984040
    [Abstract] [Full Text] [Related]

  • 47. Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting.
    Callen JP, Kulick KB, Stelzer G, Fowler JF.
    J Am Acad Dermatol; 1986 Dec 15; 15(6):1227-37. PubMed ID: 3543071
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Drug-induced lupus erythematosus.
    Vedove CD, Del Giglio M, Schena D, Girolomoni G.
    Arch Dermatol Res; 2009 Jan 15; 301(1):99-105. PubMed ID: 18797892
    [Abstract] [Full Text] [Related]

  • 50. Subacute cutaneous lupus erythematosus on the lines of Blaschko.
    Röckmann H, Feller G, Schadendorf D, Goerdt S.
    Eur J Dermatol; 2006 Jan 15; 16(3):302-6. PubMed ID: 16709500
    [Abstract] [Full Text] [Related]

  • 51. Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions.
    Spann CR, Callen JP, Klein JB, Kulick KB.
    J Rheumatol; 1988 Feb 15; 15(2):256-61. PubMed ID: 3258916
    [Abstract] [Full Text] [Related]

  • 52. Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
    McCourt C, Somerville J, McKenna K.
    Eur J Dermatol; 2010 Feb 15; 20(6):860-1. PubMed ID: 20974555
    [No Abstract] [Full Text] [Related]

  • 53. Pathogenesis of anti-Ro/SS-A autoantibody-associated cutaneous lupus erythematosus.
    Sontheimer RD, McCauliffe DP.
    Dermatol Clin; 1990 Oct 15; 8(4):751-8. PubMed ID: 2249366
    [Abstract] [Full Text] [Related]

  • 54. Subacute cutaneous lupus erythematosus--the annular variant. A histological and ultrastructural study of five cases.
    Murphy JK, Stephens C, Hartley T, Das AK, Hughes GR, McKee PH.
    Histopathology; 1991 Oct 15; 19(4):329-36. PubMed ID: 1937412
    [Abstract] [Full Text] [Related]

  • 55. Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus.
    Sontheimer RD, Stastny P, Gilliam JN.
    J Clin Invest; 1981 Jan 15; 67(1):312-6. PubMed ID: 7451656
    [Abstract] [Full Text] [Related]

  • 56. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
    Popovic K, Nyberg F, Wahren-Herlenius M, Nyberg F.
    Arthritis Rheum; 2007 Jan 15; 56(1):255-64. PubMed ID: 17195229
    [Abstract] [Full Text] [Related]

  • 57. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
    Janssens AS, Lashley EE, Out-Luiting CJ, Willemze R, Pavel S, de Gruijl FR.
    Exp Dermatol; 2005 Feb 15; 14(2):138-42. PubMed ID: 15679584
    [Abstract] [Full Text] [Related]

  • 58. Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma.
    Pramatarov K, Vassileva S, Miteva L.
    J Am Acad Dermatol; 2000 Feb 15; 42(2 Pt 1):286-8. PubMed ID: 10642688
    [Abstract] [Full Text] [Related]

  • 59. A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis.
    Mayet WJ, Bachmann M, Pfeifer K, Schröder HC, Müller WE, Gudat W, Korting GW, Meyer zum Büschenfelde KH.
    Eur J Clin Invest; 1988 Oct 15; 18(5):465-71. PubMed ID: 3147897
    [Abstract] [Full Text] [Related]

  • 60. Subacute cutaneous lupus erythematosus presenting as erythroderma.
    DeSpain J, Clark DP.
    J Am Acad Dermatol; 1988 Aug 15; 19(2 Pt 2):388-92. PubMed ID: 2970478
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.